Starling Oncology, Inc. Accounts Receivable, Credit Loss Expense (Reversal)
Starling Oncology, Inc. (DFPH) reported Accounts Receivable, Credit Loss Expense (Reversal) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2026-03-12
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-06-30 was $0.00.
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2025 was $0.00.
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2023 was $2.02M, a 324.37% increase from fiscal 2022.
- Starling Oncology, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2022 was $476.00K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $1.99M derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $1.99M derived: sum of 3 quarters · filed 2025-03-26 | $2.02M derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $1.99M derived: sum of 2 quarters · filed 2025-03-26 | $2.02M derived: sum of 3 quarters · filed 2025-03-26 | $2.02M derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $2.02M derived: sum of 2 quarters · filed 2025-03-26 | $2.02M derived: sum of 3 quarters · filed 2025-03-26 | $2.02M 10-K · filed 2025-03-26 |
| 2023-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $30.00K derived: sum of 2 quarters · filed 2024-11-13 | $31.00K 10-Q · filed 2024-11-13 | $105.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$2.00K 10-Q · filed 2024-08-13 | $72.00K derived: sum of 3 quarters · filed 2024-08-13 | $215.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-14 | $75.00K derived: sum of 2 quarters · filed 2024-05-14 | $218.00K derived: sum of 3 quarters · filed 2024-05-14 | $323.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $217.00K derived: sum of 2 quarters · filed 2024-03-28 | $322.00K derived: sum of 3 quarters · filed 2024-03-28 | $476.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $248.00K derived: sum of 2 quarters · filed 2023-11-08 | $402.00K 10-Q · filed 2023-11-08 | $652.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $259.00K 10-Q · filed 2023-08-09 | $509.00K derived: sum of 3 quarters · filed 2023-08-09 | $564.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $154.00K 10-Q · filed 2023-05-10 | $404.00K derived: sum of 2 quarters · filed 2023-05-10 | $459.00K derived: sum of 3 quarters · filed 2023-05-10 | -$263.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $305.00K derived: sum of 2 quarters · filed 2023-03-16 | -$417.00K derived: sum of 3 quarters · filed 2023-03-16 | -$417.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$667.00K derived: sum of 2 quarters · filed 2022-11-09 | -$667.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$722.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $4.23M 10-K · filed 2022-03-11 |